Form 4 for CLNN Clene Inc.
Accepted 2026-04-30 17:54:39 ET · period of report 2026-04-28 · accession 0001835544-26-000017 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2026-04-30 17:54 | 2026-04-28+ | CLNN | Ugwumba Chidozie | 10% | S - Sale | $5.78 | -19.5K | 277.6K | -7% | -$112.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-28 | S | D | 1,591 | $5.90 | 295,475 | I By SymBiosis II, LLC | — | — | |
| 2 | Common | Common Stock | 2026-04-29 | S | D | 12,170 | $5.63 | 283,305 | I By SymBiosis II, LLC | — | — | |
| 3 | Common | Common Stock | 2026-04-30 | S | D | 5,736 | $6.08 | 277,569 | I By SymBiosis II, LLC | — | — |